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Hepatitis B (HBV) infection is an important public health concern all over the globe. As a result of 
its asymptomatic nature, its prevalence among apparently healthy individuals becomes relevant for 
studies. Hence the prevalence survey of hepatitis B virus was conducted among apparently 
healthy young individuals. A total of two hundred samples were screened from volunteer subjects 
for Hepatitis B surface Antigen (HBsAg), using the one step immune-chromatographic test strip 
manufactured by Dia Spot® Diagnostics. Questionnaires were administered to obtain relevant 
information and demographic data. Overall result showed that 11 (5.5%) of the subjects tested 
were found to be positive. The highest prevalence was found among subjects aged 22-26 years 
with 7.8% prevalence compared to those aged 12-21 years with 4.4% prevalence (P=0.1012); 
(p˃0.05). Based on demographic factors, female workers tend to demonstrate high positivity of 











12.5% compared to male with 10.0% prevalence, (P=0.4929); (p˃0.05). Subjects involved with 
risky behavioral pattern by the use of unsterilized objects recorded a high prevalence of 5.3%, 
(P=0.5748); (p˃0.05) among female subjects. Serum Alanine amino-tranferases result showed no 
significant difference among the positive subjects. The results showed some measure of 
prevalence among the study population. It therefore becomes pertinent that the community be 
enlightened on the possible risk of infection by the virus. Efforts should be made to ensure 
vaccination against this infectious agent is intensified. 
 
 




The term viral hepatitis usually describes 
infections caused by agents whose primary 
tissue tropism is the liver. Hepatitis B Virus 
(HBV) has assumed a major public health 
concern worldwide, but more prevalent in the 
developing countries [1,2]. More than 2 billion 
individuals are infected with HBV world-wide 
while some 280 million are chronic carriers 
thereby harboring the virus in their liver. About 2 
million of these carriers die each year as a result 
of cirrhosis or primary liver cell cancer induced 
by the virus. Other hepatic conditions can also 
be caused by an overactive immune system, 
drugs, alcoholism, chemicals, and environmental 
toxins [3]. 
 
Viral hepatitis currently affects millions of children 
and adults, WHO estimates that in 2015, 257 
million people were living with chronic hepatitis B 
infection while an estimated 887 000 deaths 
were recorded, mostly from cirrhosis and hepato-
cellular carcinoma (i.e. primary liver cancer).As 
at 2016, 27 million people (10.5% of all people 
estimated to be living with hepatitis B) were 
aware of their infection, while 4.5 million (16.7%) 
of the people diagnosed were on treatment [4]. 
 
According to the WHO report, Sub-Saharan 
Africa is considered to be a region of high 
endemicity with an average carrier rate of 10 - 
20% in the general population. However, 70 to 
95% of adults in the Sub-Sahara have at least 
one marker for HBV infection. In West Africa, it 
has been estimated that 40% of children will be 
infected by two years of age and above 90% by 
age of ten years, while chronic carrier rate will be 
20% among these set of children [5,6]. Neonates 
born of chronically infected mothers have a 70-
90% risk of the infection progressing to a chronic 
phase [7]. 
 
HBV is also carried in other body fluids, including 
saliva, tears, semen and vaginal secretions. 
Depending on the epidemiological pattern within 
a geographic area, the main ways of 
transmission are sexual intercourse, parental 
contact or infection of the baby at birth from an 
infected mother [8]. A chronic carrier rate above 
7% in a population is classified as hyper 
endemic. Studies done in Nigeria showed HBV 
carriage rate in the range of 9 to 39% [9,10]. 
 
HBV infection is highly endemic in Nigeria 
providing a prevalence range within the 
estimated prevalence in sub-Saharan Africa [11]. 
Several studies in Nigerian children have 
recorded prevalence rates of hepatitis B surface 
antigen (HBsAg) ranging from 4.1% to 44.7% 
varying from one locality to another. Some of 
these studies however were hospital based with 
obvious limitations where different screening 
methods were used [12]. Early diagnosis and 
treatment can help prevent liver damage. 
Hepatitis B vaccine is 95% effective in preventing 
infection and its chronic consequences; it was 
the first vaccine against a major human cancer 
[13]. This study was therefore carried out to 
detect the presence of HBsAg among apparently 
healthy individuals at our locations of study. 
 
2. MATERIALS AND METHODS 
 
2.1 Study Population 
 
The study areas are selected secondary schools 
within Omu-aran community. Two hundred (200) 
blood samples were collected from apparently 
healthy volunteers, which include both genders. 
The selection of these schools was as a result of 
preliminary investigations conducted amongst 
students with regards to lifestyles and symptoms 
suspected to be an indicator for the HBV 
infection. 
 
2.2 Ethical and Consent Consideration 
 
2.2.1 Ethical permit 
 
A proposal of the project was submitted to the 











on Health related Research who subsequently 
approved the protocol for this study. All 
procedures complied with the declaration of 
Helsinki on research involving human subjects. 
 
Subjects who gave informed consent and are 
asymptomatic for HBV by routine screening, 
were included in the study, while subjects who 
had once been vaccinated with the required 
three doses of the HBV vaccine and those who 
declined to offer consent were excluded from the 
study. 
 
Well-structured questionnaire were used to 
obtain relevant information and demographic 
data from the study subjects. 
 
2.3 Collection and Processing of Samples 
 
Three (3 ml) of blood samples were collected 
aseptically by venipuncture using Syringe and 
needle. Each blood sample was transferred from 
the syringe into a carefully labeled plastic 
microtitre tube containing ethylene 
diaminetetraacetic acid (EDTA) and stored in the 
refrigerator at 4°C. Each resultant supernatant 
(Plasma) was carefully decanted into a new 
labeled tube and stored at -20°C until ready for 
use. 
 
2.4 Laboratory Assay 
 
Assay of collected sample was carried out using 
the HBsAg test strip manufactured by Dia Spot® 
Diagnostics, is a rapid chromatographic immune 
assay for the qualitative detection of hepatitis B 
surface antigen in serum or plasma. And can be 
read in-vitro having more than 99.9% sensitivity 
and 97.0% specificity. The interpretation of test 
results was performed according to the 
manufacturer’s specifications. Blood levels of 
alanine amino-transferase (ALT) and aspartate 
amino-transferase (AST) were analyzed using an 
automated chemistry analyzer (Cobas Integra 
400™; Roche, Mannheim, Germany). The test 
was carried out and interpreted according to the 
manufacturer’s instructions. 
 
2.5 Statistical Analysis 
 
Results were presented as percentages and 
frequencies while Data analysis was carried out 
using SPSS 10.0 software package. A p-value 
less than or equal 0.05 was considered 
significant. Chi-square (X
2
) test was used to 
analyze categorical variables. 
 




A total of 200 samples were tested for HBsAg. 
The age range of the subjects used in this study 
was 12 to 26 years. Most of the blood samples 
collected were from the female subjects 
139(69.5%)] While 61(30.5%) was from the 
males. The female: male ratio was 3:1 (Table 1). 
Of the 200 samples tested for HBsAg, 189 
(94.5%) tested negative while only eleven (11) 
tested positive giving a prevalence of 5.5%. 
 
Considering the age group, subjects aged 22-26 
years, recorded the highest prevalence of 7.8%, 
while subjects aged 17-21 years gave a 
prevalence of 5.7%. However, subjects aged 12-
16 years showed a prevalence of 3.6%. Based 
on gender distribution, the prevalence of HBsAg 
in females which is 3.5% is higher compared to 
the males, which is 2.0% there was no statistical 
significance between the age groups and gender 
(p˃0.05) with the value p=0.1012, as shown in 
Table 1. 
 
The result based on educational background 
showed a prevalence of 11.4% among subjects 
who had no educational background, and 3.0% 
prevalence among secondary school students 
and 0% prevalence among students in tertiary 
institution with the value p=0.5879 as shown in 
Table 2. 
 










Males Female Male Female Male Female 
12-16 83 15(7.5%) 68(34.0%) 1(0.5%) 2(1.0%) 14(7.0%) 66(33.0%) 
17-21 53 16(8.0%) 37(18.5%) 1(0.5%) 2(1.0%) 15(7.5%) 35(17.5%) 
22-26 64 30(15.0%) 34(17.0) 2(1.0%) 3(1.5%) 28(14.0%) 31(15.5%) 






















Male Female Male Female Male Female 
None 70 30(42.9%) 40(57.1%) 3(10.0%) 5(12.5%) 27(90.0%) 35(87.5%) 
Secondary 100 21(21.0%) 79(79.0%) 1(4.8%) 2(2.5%) 20(95.2%) 77(97.5%) 
Tertiary 30 10(33.3%) 20(66.7%) 0(0%) 0(0%) 10(100%) 20(100%)  
Total 200 61(30.5%) 139(69.5%) 4(6.6%) 7(5.0%) 57(93.4%) 34(24.5%) 
P=0.5879 
 








Males Female Male Females  Male Female 
Students 130 31(23.8) 99(76.2%) 1(3.2%) 2(2.0%) 30(96.8%) 97(98.0) 
Workers 70 30(42.9) 40(57.1%) 3(10.0%) 5(12.5%) 27(90.0%) 35(87.5) 
Total 200 61(30.5) 139(69.5) 4(6.6%) 7(5.0%) 57(93.4%) 132(95.0%) 
P=0.4929 
 




Number tested Number of positive 
subjects 
Number of negative 
subjects 




190 59(31.1%) 131(68.9%) 4(6.8%) 7(5.3%) 55(93.2%) 124(94.7%) 
Multiple sex 
partners 
64 24(37.5%) 40(62.5%) 2(8.3%) 5(12.5%) 22(91.7%) 35(87.5%) 
Alcohol 
consumption 
24 20(83.3%) 4(16.7%) 2(10.0%) 0(0%) 18(90.0%) 4(100%) 
P=0.5748 
 











Male Females Males Female Male Female 
Previous History 
of STDs 




17 2(11.8%) 15(88.2%) 0(0%) 0(0%) 2(50.0%) 15(50.0%) 
Previous History 
of surgery 
5 2(40.0%) 3(60.0%) 0(0%) 0(0%) 2(50.0%) 3(50.0%) 
(P˃0.05) 
 
Based on demographic factors, a 2.3% 
prevalence among students and 11.4% 
prevalence among workers was recorded 
(P=0.4929) as shown in Table 3. 
 
Based on risky behaviors, 5.8% prevalence was 
recorded among subjects with history of using 
unsterilized objects in the past, 10.9% 
prevalence was recorded among subjects who 
had more than one sex partners and 8.3% 
prevalence among subject that indulge in 
alcohol, (p=0.5748) shown in Table 4. Based on 
clinical history, 50.0% prevalence was recorded 
among subjects who had once been diagnosed 
with STDs, Table 5. 
 
Table 6 shows the ALT and AST result for the 
positive samples. All 11(100%) subjects recorded 
a normal result while none (0%) of the subjects 











Table 6. Determination of serum Alanine aminotransfarase level (ALT) and Aspartate 














12-16 Males 1(6.7%) 1(6.7%) 0(0%) 1(6.7%) 0(0%) 
 Females 2(13.3%) 2(13.3%) 0(0%) 2(13.3%) 0(0%) 
17-21 Males 1(6.3%) 1(6.3%) 0(0%) 1(6.3%) 0(0%) 
 Females 2(12.5%) 2(12.5%) 0(0%) 2(12.5%) 0(0%) 
22-26 Males 2(6.7%) 2(6.7%) 0(0%) 2(6.7%) 0(0%) 
 Females 3(8.8%) 3(8.8%) 0(0%) 3(8.8%) 0(0%) 





Worldwide, viral hepatitis is the commonest 
cause of liver dysfunction. The prevalence of 
HBV varies between 2% in developed countries 
where the prevalence is low to about 8% in 
developing countries where infection is endemic 
with sex, age and socioeconomic status as 
important risk factors for infection [14]. 
 
From this study, the overall prevalence of HBsAg 
among apparently healthy individuals in Omu-
aran community was 5.5%. This is comparable to 
the result obtained by Ndako et al. [15] who 
recorded a prevalence of 5.3% among alcoholic 
subjects and 5.4% prevalence among blood 
donors reported in a study conducted at Benin 
City [16]. Another study conducted by Ugwuja 
and Ugwu [17] showed a 4.1% prevalence of 
HBsAg among adolescents in Abakaliki, South-
Eastern Nigeria, which is lower than the result 
obtained in this study. 
 
Okonko et al. [18] reported a lower prevalence of 
2.5% among apparently healthy blood donors in 
Port Harcourt which is similar to the 2.4% 
prevalence recorded in a similar study conducted 
in Yola, Nigeria- according to the report of 
Olokoba et al. [19], and a Null result (0.0%) 
reported by Alli et al. [20] among blood donors in 
Ibadan. The 5.5% prevalence of HBV in this 
study is higher than the prevalence rate of 1.6% 
among blood donors in Port Harcourt reported by 
Ejele and Ojule [21] and 4.0% prevalence 
reported in the work of Abdalla et al. [22], among 
Kenyan donors. 
 
The differences in prevalence in this study could 
be attributed to difference in population selection. 
Results obtained showed that 7.8% of the 
subjects in the age group 22-26 years had the 
highest prevalence of HBsAg compared to their 
counterparts in age group 12 to 21 with 
prevalence of 4.4%. This is similar to the work of 
Buseri et al. [23], who reported HBV prevalence 
to be highest among subjects aged group 18-27 
years. 
 
The high prevalence rate of HBV was recorded 
among subjects aged 22-26 in this study which 
suggests that most of these subjects may have 
acquired the infection through risky lifestyles or 
behaviors such as the use of unsterilized objects 
while others may have acquired the infection, 
through sexual promiscuity. The classification of 
high endemicity from HBV infection has been 
greater than 7% in an adult population as 
reported by Uneke et al. [24]; Okonko and Udeze 
[25], but comparatively low in this study. The 
incidence of HBV transmission through sex and 
unsterilized objects could be reduced with the 
introduction of HBV vaccines and public 
enlighten campaign against this virus [26,27]. 
 
Based on gender it was found that male subjects 
recorded a higher seropositivity for HBsAg 
(6.6%) compared to their female counterparts 
(5.0%). The difference was however, not 
significant (p > 0.05); the reason for this 
difference might be due to larger number of 
female volunteers used in this study. Uneke et al. 
[24] suggested that both sexes are equally 
susceptible to HBV infection while gender may 
not necessarily be an important epidemiological 
determinant of HBV infection. Mehmet et al. [28] 
reported that males had higher prevalence rate 
than females in both rural and urban areas with 
observation that male sex was an important risk 
factor for HBsAg positivity, which is contrary to 
the result obtained in this study. Balogun et al. 
[29] in their study reported higher prevalence of 
HBsAg among males than females in Lagos, 
Nigeria. 
 
A similar study also reported a higher HBsAg 











subjects attending Dental Clinic at the University 
College Hospital (UCH), Ibadan and this was 
suggested to be due to shorter HBsAg carrier 
rate in females than males [30,31,32]. In 
addition, the reason for the high infection rate 
among the males may be due to habits such as 
multiple sexual partnership and poor educational 
background which affect enlightenment and 
promote the transmission of the virus [32]. Lack 
of statistically significant difference in the 
prevalence between males and females in this 
study suggests that both genders are equally 
exposed to HBV infection [33,17]. Based on 
Educational background, a prevalence of 11.4% 
among subjects without any Educational 
background were found to be higher than the 
3.0% prevalence among secondary school 
students and the 0% prevalence among those 
with tertiary education, which shows that 
educational background may assist at prevention 
of transmission by enlightenment strategies. 
 
Analysis based on clinical history of the subjects 
showed 50.0% prevalence was recorded among 
subjects with history of Sexually Transmitted 
Diseases (STDs) compared to 0% prevalence 
recorded among subjects with history of blood 
transfusion and surgery respectively. Based on 
demographic features, prevalence of 11.4% 
among the workers was higher than the 4.3% 
prevalence among students, possible reasons 
might be due to lack of awareness  as most of 
them do not have knowledge of the virus and are 
at high risk of infection [34,18]. Risky behavioral 
pattern showed 5.5% prevalence among 
individuals who were exposed to unsterilized 
objects compared to 3.5% and 1.0% prevalence 
among those that have more than one sex 
partner and subjects involved in alcoholism 
respectively, which are both high predisposing 
factors in the population as observed by Ndako 
et al. [35] in a study among apparently healthy 
individuals in an Urban setting in North central 
Nigeria. 
 
The Amino-trasferase levels of the individuals 
within the age groups used for the study were 
normal. The mean serum alanine amino 
transferase (ALT) enzyme level of subjects who 
tested positive was normal. (ALT normal range 
for study area/center: 1-12 IU/L). Which had no 
significant difference from aspartate amino 
transferase (AST) enzyme level (AST normal 
limit for study area/center: 1-18 IU/L). The 
transaminase enzyme levels in this study could 
also reflect the clinical characteristics of the 
study population involved. No abnormal ALT and 
AST levels were recorded as 100% of the results 
all the positive samples showed that ALT and 




This outcome of this research calls for a prompt 
enlightenment through mass screening of 
members of the community to identify those with 
the hepatitis B infection, establishing appropriate 
measures to manage the infection such as mass 
immunization of the uninfected population 
against the virus and periodic public health 
education to enlighten the entire community on 
the scourge of HBV infection. The possible risk 
factors and routes of infection are required as a 
measure to prevent spread of infection in the 
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